BCM
CANO

Bayesian Capital Management’s Cano Health, Inc. CANO Stock Holding History

Bayesian Capital Management’s Portfolio CANO Stock Details CANO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,341
Closed -$122K – 1140
2023
Q1 		$122K Buy
+1,341
New +$182K 0.02% 666
2022
Q3 		– Sell
-799
Closed -$350K – 1090
2022
Q2 		$350K Buy
799
+573
+254% +$299K 0.07% 429
2022
Q1 		$143K Sell
226
-104
-32% -$65.6K 0.02% 678
2021
Q4 		$294K Buy
+330
New +$347K 0.09% 258

Other funds holding CANO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCP
Diameter Capital Partners New York $1.07B AUM 152.29% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EHI
Eagle Health Investments Greenwich, Connecticut $572M AUM 67.49% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return